Study of the Efficacy of an Investigational Drug in Adult Patients With Non Small-Cell Lung Cancer (NSCLC)

Completed · Phase 2

Conditions studied: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

In brief

The primary goal of the study is to evaluate an investigational drug's effectiveness as a treatment for Non small-cell lung cancer (NSCLC)

Key facts

Study ID

NCT00034957

Run by

Pfizer

Expected to finish

2002-10-01

Last updated by the study team

2012-02-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Research Center — Berkeley, California, United States
• Research Center — Greenbrae, California, United States
• Research Center — Los Angeles, California, United States
• Research Center — Rancho Mirage, California, United States
• Research Center — Chicago, Illinois, United States
• Research Center — Louisville, Kentucky, United States
• Research Center — West Boylston, Massachusetts, United States
• Research Center — Ann Arbor, Michigan, United States
• Research Center — Lebanon, New Hampshire, United States
• Research Center — Nashville, Tennessee, United States
• Research Center — Arlington, Texas, United States
• Research Center — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.